HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vinayak Khattar Selected Research

Single-Chain Antibodies

11/2022Systemic Checkpoint Blockade by PD-L1 Single-Chain Antibody Confers Potent Antitumor Immunity and Long-term Survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vinayak Khattar Research Topics

Disease

5Neoplasms (Cancer)
11/2022 - 10/2013
4Breast Neoplasms (Breast Cancer)
11/2022 - 01/2015
2Carcinoma (Carcinomatosis)
02/2015 - 01/2015
1Hematologic Neoplasms (Hematological Malignancy)
11/2022
1Colonic Neoplasms (Colon Cancer)
03/2019

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
12/2020 - 10/2013
1Single-Chain AntibodiesIBA
11/2022
1Immune Checkpoint InhibitorsIBA
11/2022
1LigandsIBA
12/2020
1Death Domain ReceptorsIBA
12/2020
1OsteoprotegerinIBA
12/2020
1TNF-Related Apoptosis-Inducing LigandIBA
12/2020
1AutoantigensIBA
03/2019
1VaccinesIBA
03/2019
1geldanamycinIBA
02/2015
1quinone (benzoquinone)IBA
02/2015
1tanespimycin (17AAG)IBA
02/2015
1Adenosine Triphosphate (ATP)IBA
02/2015
1Rifabutin (Ansamycin)FDA Link
02/2015
1Cell Cycle ProteinsIBA
02/2015
1Proteasome InhibitorsIBA
01/2015

Therapy/Procedure

2Therapeutics
11/2022 - 12/2020
1Immunotherapy
03/2019